Toggle navigation
Campus Access
About MPG.eBooks
Skip to content
Search Tips
Home
>
Search: object ((management points) OR (management joint))*
Language
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
All Fields
Title
Person
Topic
ISBN/ISSN
Year
Collection
Advanced
Retain my current filters
author_facet:"Canadian Agency for Drugs and Technologies in Health"
Showing
1
-
8
of
8
Search:
'object ((management points) OR (management joint))*'
,
query time: 0.02s
Book List
0
Sort:
Relevance
Year Descending
Year Ascending
Author
Title
Read Now
1
Obesity
management
interventions delivered in primary care for patients with osteoarthritis : a review of the clinical effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...While effective weight
management
is a laudable health goal for all, it is especially important...
”
Read Now
2
Obesity
management
interventions delivered in primary care for patients with osteoarthritis : a review of the clinical effectiveness
Published 2014
Canadian Agency for Drugs and Technologies in Health
“
...While effective weight
management
is a laudable health goal for all, it is especially important...
”
Read Now
3
Canakinumab (Ilaris)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
..., with clinical manifestations mainly related to
joint
inflammation and including
joint
effusion,
joint
line...
”
Read Now
4
Canakinumab (Ilaris)
Published 2016
Canadian Agency for Drugs and Technologies in Health
“
..., with clinical manifestations mainly related to
joint
inflammation and including
joint
effusion,
joint
line...
”
Read Now
5
Golimumab (Simponi) IV : in combination with methotrexate (MTX) for the treatment of adult patients with moderately to severely active rheumatoid arthritis
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...Rheumatoid arthritis (RA) is a chronic, inflammatory disease characterized by
joint
swelling,
joint
...
”
Read Now
6
Golimumab (Simponi) IV : in combination with methotrexate (MTX) for the treatment of adult patients with moderately to severely active rheumatoid arthritis
Published 2015
Canadian Agency for Drugs and Technologies in Health
“
...Rheumatoid arthritis (RA) is a chronic, inflammatory disease characterized by
joint
swelling,
joint
...
”
Read Now
7
Optimal care of chronic, non-healing, lower extremity wounds : a review of clinical evidence and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
...% to 3% percent of the healthcare budgets in developed countries. The goal of chronic wound
management
...
”
Read Now
8
Optimal care of chronic, non-healing, lower extremity wounds : a review of clinical evidence and guidelines
Published 2013
Canadian Agency for Drugs and Technologies in Health
“
...% to 3% percent of the healthcare budgets in developed countries. The goal of chronic wound
management
...
”
Back
Narrow Search
Remove Filters
Clear Filter
Author: Canadian Agency for Drugs and Technologies in Health
Year of Publication
From:
To:
Classification
700 - The arts; fine & decorative arts
6
610 - Medicine & health
2
612 - Human physiology
2
Language
English
8
Collection
National Center for Biotechnology Information
8
Author
Canadian Agency for Drugs and Technologies in Health
Search Tools
Get RSS Feed
Share Search
https://ebooks.mpdl.mpg.de/ebooks/Search/Results?filter%5B%5D=author_facet%3A%22Canadian+Agency+for+Drugs+and+Technologies+in+Health%22&lookfor=object+%28%28management+points%29+OR+%28management+joint%29%29%2A&type=AllFields
Send by Email
×
Loading...